- Home
- NXTC vs MMA Comparison
NXTC vs MMA Comparison
Compare NXTC & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- MMA
- Stock Information
- Founded
- NXTC 2015
- MMA 2013
- Country
- NXTC United States
- MMA Australia
- Employees
- NXTC N/A
- MMA N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- MMA
- Sector
- NXTC Health Care
- MMA
- Exchange
- NXTC Nasdaq
- MMA Nasdaq
- Market Cap
- NXTC 13.0M
- MMA 11.1M
- IPO Year
- NXTC 2019
- MMA 2024
- Fundamental
- Price
- NXTC N/A
- MMA $1.64
- Analyst Decision
- NXTC Strong Buy
- MMA
- Analyst Count
- NXTC 2
- MMA 0
- Target Price
- NXTC $25.50
- MMA N/A
- AVG Volume (30 Days)
- NXTC 10.5K
- MMA 1.1M
- Earning Date
- NXTC 11-06-2025
- MMA 01-01-0001
- Dividend Yield
- NXTC N/A
- MMA N/A
- EPS Growth
- NXTC N/A
- MMA N/A
- EPS
- NXTC N/A
- MMA N/A
- Revenue
- NXTC N/A
- MMA $407,412.00
- Revenue This Year
- NXTC N/A
- MMA N/A
- Revenue Next Year
- NXTC N/A
- MMA N/A
- P/E Ratio
- NXTC N/A
- MMA N/A
- Revenue Growth
- NXTC N/A
- MMA N/A
- 52 Week Low
- NXTC $2.69
- MMA $0.60
- 52 Week High
- NXTC $19.20
- MMA $4.11
- Technical
- Relative Strength Index (RSI)
- NXTC N/A
- MMA 54.32
- Support Level
- NXTC N/A
- MMA $1.40
- Resistance Level
- NXTC N/A
- MMA $1.60
- Average True Range (ATR)
- NXTC 0.00
- MMA 0.11
- MACD
- NXTC 0.00
- MMA -0.03
- Stochastic Oscillator
- NXTC 0.00
- MMA 13.89
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.